Differentiating disease subtypes by using pathway patterns constructed from gene expressions and protein networks

Gene expression profiles differ in different diseases. Even if diseases are at the same stage, such diseases exhibit different gene expressions, not to mention the different subtypes at a single lesion site. Distinguishing different disease subtypes at a single lesion site is difficult. In early cases, subtypes were initially distinguished by doctors. Subsequently, further differences were found through pathological experiments. For example, a brain tumor can be classified according to its origin, its cell-type origin, or the tumor site. Because of the advancements in bioinformatics and the techniques for accumulating gene expressions, researchers can use gene expression data to classify disease subtypes. Because the operation of a biopathway is closely related to the disease mechanism, the application of gene expression profiles for clustering disease subtypes is insufficient. In this study, we collected gene expression data of healthy and four myelodysplastic syndrome subtypes and applied a method that integrated protein-protein interaction and gene expression data to identify different patterns of disease subtypes. We hope it is efficient for the classification of disease subtypes in adventure.

[1]  Yo-Cheng Chang,et al.  Revealing pathway maps of renal cell carcinoma by gene expression change , 2014, Comput. Biol. Medicine.

[2]  I. Jurisica,et al.  Unequal evolutionary conservation of human protein interactions in interologous networks , 2007, Genome Biology.

[3]  M. Cazzola,et al.  Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells. , 2009 .

[4]  J. MacQueen Some methods for classification and analysis of multivariate observations , 1967 .

[5]  M. Dyer,et al.  mb-1: A New Marker for B-Lineage Lymphoblastic Leukemia , 1993 .

[6]  Noam Harpaz,et al.  Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. , 2002, Gastroenterology.

[7]  R. Tothill,et al.  Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.

[8]  U. V. Kulkarni,et al.  Prediction of Cancer Subtypes using Fuzzy Hypersphere Clustering Neural Network , 2011 .

[9]  E. Jaffe,et al.  CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. , 1995, Blood.

[10]  Doulaye Dembélé,et al.  Fuzzy C-means Method for Clustering Microarray Data , 2003, Bioinform..

[11]  Eva Budinska,et al.  A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome. , 2010, Leukemia research.

[12]  Tiziana di Matteo,et al.  Hierarchical Information Clustering by Means of Topologically Embedded Graphs , 2011, PloS one.

[13]  Zarita Zainuddin,et al.  Reliable multiclass cancer classification of microarray gene expression profiles using an improved wavelet neural network , 2011, Expert Syst. Appl..

[14]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[15]  Paul S Mischel,et al.  Gene expression profiling identifies molecular subtypes of gliomas , 2003, Oncogene.

[16]  D. Arber,et al.  Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. , 1996, American journal of clinical pathology.

[17]  W. Weidong,et al.  Identification of let-7a-2-3p or/and miR-188-5p as Prognostic Biomarkers in Cytogenetically Normal Acute Myeloid Leukemia , 2015, PloS one.

[18]  Zarita Zainuddin,et al.  Reliable epileptic seizure detection using an improved wavelet neural network. , 2013, The Australasian medical journal.